Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of dapagliflozin in combination with metformin in adults with Type 2 diabetes; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23